Study to Evaluate the Safety of Albuterol in a Dry Powder Inhaler
- Study Title
- A Twelve Month Long Term Safety Study to Evaluate the Safety of Albuterol in a Dry Powder Inhaler With Both Repeated and as Needed Dosing
- Teva Identifier
- ABS-AS-306
- ClinicalTrials.gov Identifier
- NCT01218009
- Study Status
- Terminated
- Trial Condition(s)
- Asthma
- Interventions
- Drug: Placebo Spiromax | Drug: Albuterol Spiromax
Study Description
Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
- Gender
- Female, Male
- Age group
- Child, Adult, Older Adult
- Age Range
- 12 Years and older
- Trial Duration
- 10/01/2010 - 12/01/2010
- Phase
- Phase 3
